JP2014518267A5 - - Google Patents

Download PDF

Info

Publication number
JP2014518267A5
JP2014518267A5 JP2014518932A JP2014518932A JP2014518267A5 JP 2014518267 A5 JP2014518267 A5 JP 2014518267A5 JP 2014518932 A JP2014518932 A JP 2014518932A JP 2014518932 A JP2014518932 A JP 2014518932A JP 2014518267 A5 JP2014518267 A5 JP 2014518267A5
Authority
JP
Japan
Prior art keywords
methyl
oxabicyclo
pyrido
ethyl
naphthyridin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2014518932A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014518267A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/044267 external-priority patent/WO2013003383A1/en
Publication of JP2014518267A publication Critical patent/JP2014518267A/ja
Publication of JP2014518267A5 publication Critical patent/JP2014518267A5/ja
Pending legal-status Critical Current

Links

JP2014518932A 2011-06-27 2012-06-26 細菌感染症の治療のための架橋二環式化合物 Pending JP2014518267A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161501692P 2011-06-27 2011-06-27
US61/501,692 2011-06-27
PCT/US2012/044267 WO2013003383A1 (en) 2011-06-27 2012-06-26 Bridged bicyclic compounds for the treatment of bacterial infections

Publications (2)

Publication Number Publication Date
JP2014518267A JP2014518267A (ja) 2014-07-28
JP2014518267A5 true JP2014518267A5 (enExample) 2015-08-06

Family

ID=46514782

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014518932A Pending JP2014518267A (ja) 2011-06-27 2012-06-26 細菌感染症の治療のための架橋二環式化合物

Country Status (6)

Country Link
US (1) US20140243302A1 (enExample)
EP (1) EP2723737A1 (enExample)
JP (1) JP2014518267A (enExample)
AU (1) AU2012275499A1 (enExample)
CA (1) CA2840060A1 (enExample)
WO (1) WO2013003383A1 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201111705D0 (en) 2011-07-07 2011-08-24 Takeda Pharmaceutical Compounds and their use
JO3115B1 (ar) 2011-08-22 2017-09-20 Takeda Pharmaceuticals Co مركبات بيريدازينون واستخدامها كمثبطات daao
PE20141361A1 (es) 2011-11-15 2014-10-13 Takeda Pharmaceutical Compuesto heterociclico dihidroxi aromatico
AR089929A1 (es) * 2012-02-10 2014-10-01 Actelion Pharmaceuticals Ltd Proceso para manufacturar un derivado de naftiridina
GB201222711D0 (en) 2012-12-17 2013-01-30 Takeda Pharmaceutical Novel compounds
JP6112724B2 (ja) * 2013-10-31 2017-04-12 日本化薬株式会社 1,5−ナフチリジン誘導体およびそれを有効成分として含んでなる殺虫剤
MX369347B (es) 2014-01-06 2019-11-06 Bristol Myers Squibb Co Derivados de pirrolidinilsulfona y su uso como moduladores del receptor huerfano relacionado con retinoide gamma (ror gamma).
EP3050888A1 (en) 2015-01-27 2016-08-03 Merck Sharp & Dohme Corp. Compounds for the treatment of bacterial infections
TW201722965A (zh) 2015-08-16 2017-07-01 葛蘭素史密斯克藍智慧財產發展有限公司 用於抗菌應用之化合物
WO2017153235A1 (de) 2016-03-09 2017-09-14 Bayer Pharma Aktiengesellschaft Substituierte n-cyclo-3-aryl-1-naphthamide und ihre verwendung
AU2017276627A1 (en) * 2016-06-08 2018-12-20 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. New antibacterial compounds
CN109641899B (zh) 2016-09-09 2022-07-22 诺华股份有限公司 作为内体Toll样受体抑制剂的化合物及组合物
CA3080804A1 (en) * 2017-11-02 2019-05-09 Calico Life Sciences Llc Modulators of the integrated stress pathway
ES2912499T3 (es) 2018-06-15 2022-05-26 Bristol Myers Squibb Co Miméticos de tiodisacáridos a base de tetrahidropirano como inhibidores de galectina-3
CN108947940A (zh) * 2018-06-20 2018-12-07 天津全和诚科技有限责任公司 一种2-氧杂环丁烷衍生物的合成方法
US12391675B2 (en) 2019-01-14 2025-08-19 Innate Tumor Immunity, Inc. NLRP3 modulators
WO2020160151A1 (en) 2019-01-31 2020-08-06 Kyorin Pharmaceutical Co., Ltd. 15-pgdh inhibitors
TW202214637A (zh) 2020-06-11 2022-04-16 美商Chdi基金會股份有限公司 用於亨丁頓(huntingtin)蛋白造影之雜環化合物及造影劑
EP4253387A4 (en) 2020-11-26 2024-05-15 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Fused tricyclic compound, preparation method therefor and application thereof in medicine
CN114957056A (zh) * 2021-02-20 2022-08-30 帕潘纳(北京)科技有限公司 制备3-甲基-2-氯-4-甲基磺酰基苯甲酸甲酯及其中间体的方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR244550A1 (es) 1978-07-24 1993-11-30 Merck & Co Inc Procedimiento para obtener una composicion de antibioticos del tipo de la tienamicina con inhibidores de la dipeptidasa
EA005211B1 (ru) 1999-11-12 2004-12-30 Байоджен, Инк. Полициклоалкилпурины в качестве антагонистов аденозиновых рецепторов
CA2580621A1 (en) * 2004-09-24 2006-03-30 Actelion Pharmaceuticals Ltd New bicyclic antibiotics
DE102007026341A1 (de) 2007-06-06 2008-12-11 Merck Patent Gmbh Benzoxazolonderivate
TWI414290B (zh) * 2007-06-15 2013-11-11 Actelion Pharmaceuticals Ltd 3-胺基-6-(1-胺基-乙基)-四氫哌喃衍生物
JP5639581B2 (ja) * 2008-06-03 2014-12-10 アクテリオン ファーマシューティカルズ リミテッドActelion Pharmaceuticals Ltd 抗菌剤としての[4−(1−アミノ−エチル)−シクロヘキシル]−メチル−アミン及び[6−(1−アミノ−エチル)−テトラヒドロ−ピラン−3−イル]−メチル−アミン誘導体
WO2010043714A1 (en) * 2008-10-17 2010-04-22 Glaxo Group Limited Tricyclic nitrogen compounds used as antibacterials
TW201022279A (en) * 2008-11-14 2010-06-16 Astrazeneca Ab Chemical compounds
US8211890B2 (en) * 2008-12-12 2012-07-03 Actelion Pharmaceuticals 5-amino-2-(1-hydroxy-ethyl)-tetrahydropyran derivatives
AR076222A1 (es) * 2009-04-09 2011-05-26 Actelion Pharmaceuticals Ltd Derivados 2-hidroxietil-1h-quinolin-ona y sus analogos azaisotericos con actividad antibacteriana y composiciones farmaceuticas que los contienen

Similar Documents

Publication Publication Date Title
JP2014518267A5 (enExample)
JP2019536768A5 (enExample)
JP2014513139A5 (enExample)
RU2007147413A (ru) Аминопиперидинхинолины и их азаизостерические аналоги с антибактериальной активностью
JP2015514808A5 (enExample)
JP2013537210A5 (enExample)
ME03754B (me) Derivaтi karbazola
JPWO2023018809A5 (enExample)
TW200538128A (en) Therapeutic combinations of atypical antipsychotics with corticotropin releasing factor antagonists
RU2350616C2 (ru) Производные пиразоло- и имидазопиримидина
PE20081581A1 (es) COMPUESTOS PIRROLO[2,3-b]PIRIDINAS COMO MODULADORES DE QUINASA
JP2017520607A5 (enExample)
SG172958A1 (en) Poly (adp-ribose) polymerase (parp) inhibitors
JPWO2023018810A5 (enExample)
RU2014112931A (ru) Пиразолохинолиновое производное
JP2017535536A5 (enExample)
JP2013500247A5 (enExample)
PE20090370A1 (es) Derivados de heterociclo fusionado como inhibidores de quinasa
RU2011117412A (ru) Трициклические оксазолидиноновые антибиотические соединения
JP2014521751A (ja) 腎髄質外層カリウムチャンネルの阻害薬
JP2014513140A5 (enExample)
RU2010128543A (ru) Карбоксамидные соединения и их применение в качестве агонистов хемокиновых рецепторов
AR038366A1 (es) Compuestos de 1,2,4-triazolo [1,5-c] pirimidinas sustituidas, antagonistas del receptor de adenosina a2a, composiciones farmaceuticas, el uso de dichos compuestos para la manufactura de un medicamento para el tratamiento de enfermedades del sistema nervioso central y un kit que comprende combinacion
HRP20110942T1 (hr) (dihidro)pirolo[2,1-a]izohinolini
RU2010138648A (ru) Азатрициклические соединения антибиотиков